According to the report “Bovine Respiratory Disease Treatment Market“, published by Market Data Forecast, the global market is projected to reach USD 67.31 Million by 2021, at a CAGR of 22.4% from 2016 to 2021.
BRD refers to any disease of the lower or upper respiratory tracts in cattle and is commonly associated with lung infections, which can cause pneumonia. The disease is the most common and costliest problem encountered in stocker or feedlot calves.
The risk of bovine respiratory disease (BRD) has a significant effect on the value of cattle in the marketplace. Bovine respiratory disease can be a costly expense for cattle producers. It causes major economic losses to the producer by reducing average daily gain, feed efficiency, and overall performance of beef calves.
Global Bovine Respiratory Disease Treatment Market is segmented as follows.
1. By Type of Treatment:
2. By Geography:
The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.
About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 9985550206